[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Monday 27 September 2021
Salford GP Header Montage
Latest News:
RSS icon
Medicine, tablets, pills


This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.


This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.


For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.


How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.


  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 



Drug NameBNF CategoryComment / Usage RestrictionsDetails
L-5-Hydrotryptophan (5HTP)Not in BNFMetabolic Disorders only. (Capsules 25mg & 50mg)  
La Roche Posay Anthelios Melt In Cream Spf 50See online BNFRestriced use - Dermatology.  Approved June 2011 
Labetalol2.4 Beta-adrenoceptor blocking drugs  
Lacosamide4.8.1 Control of epilepsyNeurology only. For patients who have failed to respond to older AEDs, or for whom the older AEDS are unsuitable due to interactions, contraindications to the medication, intolerance of the medication or teratogenicity risk. Approved for adult patients. Approved for paediatrics on advice of Paediatric Neurologist.  
Lactulose1.6.4 Osmotic laxativesGastroenterology only. Approved for use in Paediatrics    
Lamotrigine4.8.1 Control of epilepsyNeurology only. Approved for paediatric use when commenced by Paediatricians / Paediatrician with expertise in epilepsy.  
Lanolin ointment with salicyclic acid13.5.2 Preparations for psoriasis  
Lanreotide8.3.4.3 Somatostatin analoguesEndocrinology only - Follow restricted high cost drug procedure before prescribing lanreotide 
Lansoprazole Orodispersible Tablet (Fastab)1.3.5 Proton pump inhibitorsFor patients unable to swallow tablets.First line choice. Omeprazole MUPs also available for intestinal failure patients and patients with short bowel and for use in PANDA (in line with RMCH). 
Lanthanum9.5.2.2 Phosphate-binding agents  


All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.